PMC:7074432 / 9508-9961 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"338","span":{"begin":0,"end":8},"obj":"Species"},{"id":"339","span":{"begin":101,"end":109},"obj":"Species"},{"id":"378","span":{"begin":313,"end":318},"obj":"Disease"},{"id":"379","span":{"begin":446,"end":453},"obj":"Disease"}],"attributes":[{"id":"A338","pred":"tao:has_database_id","subj":"338","obj":"Tax:9606"},{"id":"A339","pred":"tao:has_database_id","subj":"339","obj":"Tax:9606"},{"id":"A378","pred":"tao:has_database_id","subj":"378","obj":"MESH:D003643"},{"id":"A379","pred":"tao:has_database_id","subj":"379","obj":"MESH:D004417"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Patients were treated symptomatically and given respiratory support. Immunoglobulin was given to few patients depending upon clinical severity and response. No benefit was observed from systematic corticosteroid. Notably, early respiratory support facilitated disease recovery and improved prognosis. The risk of death was primarily associated with age, underlying chronic diseases, and median interval from the appearance of initial symptoms to dyspnea"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T17","span":{"begin":69,"end":83},"obj":"Body_part"}],"attributes":[{"id":"A17","pred":"fma_id","subj":"T17","obj":"http://purl.org/sig/ont/fma/fma62871"}],"text":"Patients were treated symptomatically and given respiratory support. Immunoglobulin was given to few patients depending upon clinical severity and response. No benefit was observed from systematic corticosteroid. Notably, early respiratory support facilitated disease recovery and improved prognosis. The risk of death was primarily associated with age, underlying chronic diseases, and median interval from the appearance of initial symptoms to dyspnea"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T96","span":{"begin":197,"end":211},"obj":"Chemical"}],"attributes":[{"id":"A96","pred":"chebi_id","subj":"T96","obj":"http://purl.obolibrary.org/obo/CHEBI_50858"}],"text":"Patients were treated symptomatically and given respiratory support. Immunoglobulin was given to few patients depending upon clinical severity and response. No benefit was observed from systematic corticosteroid. Notably, early respiratory support facilitated disease recovery and improved prognosis. The risk of death was primarily associated with age, underlying chronic diseases, and median interval from the appearance of initial symptoms to dyspnea"}

{"project":"LitCovid-sentences","denotations":[{"id":"T63","span":{"begin":69,"end":156},"obj":"Sentence"},{"id":"T64","span":{"begin":157,"end":212},"obj":"Sentence"},{"id":"T65","span":{"begin":213,"end":300},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Patients were treated symptomatically and given respiratory support. Immunoglobulin was given to few patients depending upon clinical severity and response. No benefit was observed from systematic corticosteroid. Notably, early respiratory support facilitated disease recovery and improved prognosis. The risk of death was primarily associated with age, underlying chronic diseases, and median interval from the appearance of initial symptoms to dyspnea"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T17","span":{"begin":446,"end":453},"obj":"Phenotype"}],"attributes":[{"id":"A17","pred":"hp_id","subj":"T17","obj":"http://purl.obolibrary.org/obo/HP_0002094"}],"text":"Patients were treated symptomatically and given respiratory support. Immunoglobulin was given to few patients depending upon clinical severity and response. No benefit was observed from systematic corticosteroid. Notably, early respiratory support facilitated disease recovery and improved prognosis. The risk of death was primarily associated with age, underlying chronic diseases, and median interval from the appearance of initial symptoms to dyspnea"}